  <script type="text/javascript">
    $(document).ready(function () {

    if (bowser.msie) {
       var width = 'width';
       var height = 'height';
    }
    else{
        var width = 'innerWidth';
        var height = 'innerHeight';
    }

    $( "#prev_SLIT_slide, #next_SLIT_slide" ).click(function() {
        var page = ( $(this).attr( "id" ) === "prev_SLIT_slide" ) ? 44 : 46;
        $( "span.count" ).empty().html(page + "/66" );
        $( "span#SLITslide_no" ).text(page);
        
        target = $(this).attr( "alt" );
        target = "../../programs/AIT/SLIT/" + target;

        /* make an ajax call to retrieve next slide */
        $.ajax(
          {url:target,
            cache: false,
            type: "GET",
            dataType: "html"
          }) 

        .done(function( data ) {
              $( "#SLIT_section" ).empty();
              $( "#SLIT_section" ).html( data );
        })
         .fail(function() {
             var no_data = "<table><tr><td> We are sorry, the contents you requested do not exist! </td></tr></table>";
            $( "#SLIT_section" ).html( no_data );
        });
        
    });

    $( "#SLIT_Slide38" ).click(function() {
          window.open('https://dxlink.ca/fr/programs/AIT/images/Slide38_large.jpg','_blank','' + width + '=750px,' + height + '=563px,menubar=no,location=yes,resizable=yes,scrollbars=yes,status=no');
    });

  });//end document.ready
</script>
<div class="innerContentFrame">
   <table style="width:100%;" >
      <tr valign="top">
        <td style="vertical-align:top;padding: 0 0 25px 5px; width:595px" >
      
          <div style="padding0;margin0;">
              <span class="subTitle">Effets soutenus du C-ITSL contre l’allergie au pollen de graminées : Protocole de l’étude GT-08 </span></br>
                <p style="padding-top:10px;"> <span class="thumb-screen two-line-spaced" id="SLIT_Slide38"></span><img style="float:right; margin: 0px 0px 10px 25px;cursor: pointer;" src="images/Slide38_small.jpg" width="200" height="150"/>Une efficacité clinique durable a été accompagnée d’une augmentation des IgG4 spécifiques de l’allergène (anticorps) et du facteur bloquant l’IgE qui confirment la tolérabilité clinique et immunologique pendant au moins deux ans après la fin du traitement. Aucun problème lié à l’innocuité n’est survenu pendant le suivi.</p>
                </br>
                <p class="info_reference">Référence :</br>Durham, S.R. et al. Sustained effects of grass pollen AIT. Allergy, 2011; 66(Suppl 95):50-52.</p>                      
          </div>
        </td>
         <td style="padding:0 10px 0 30px;">
          <img style="cursor: pointer;" src="../images/prev.jpg" width="28" height="28"  alt="AIT_SLIT_slide_23.html" id="prev_SLIT_slide"/>
        </td>
        <td style="padding: 0;">
          <img style="cursor: pointer;" src="../images/next.jpg" width="28" height="28" alt="AIT_SLIT_slide_25.html" id="next_SLIT_slide"/>
        </td>
    </tr> 
    </table>
</div>